Presentation THT 2023 Medical Therapies Work for HFpEF: What, When, How Presenter: Parag Goyal March 20, 2023
Presentation THT 2023 New Insights Into the Pathophysiology of HFpEF Presenter: Philipp Lurz March 20, 2023
Presentation THT 2023 The Multiverse of HFpEF: All Roads Lead to Functional Limitation Presenter: Greg Lewis March 20, 2023
Presentation THT 2023 The PRELIEVE trial: Final 1-year outcomes of the prospective Atrial Flow Regulator study in HFrEF and HFpEF patients and post-hoc responder analysis Presenter: Christina Paitazoglou March 20, 2023
Presentation THT 2023 Relationship of Subjective Health Status and Physical Functioning in Ambulatory Black and Hispanic Patients with HFpEF: the SCAN-MP Study Presenter: Lawrence Zeldin March 20, 2023
News Daily News Borderline Cost-effectiveness for SGLT2 Inhibitors in HFpEF Todd Neale March 15, 2023
News Conference News ACC 2023 How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA Todd Neale March 09, 2023
News Conference News ACC 2023 RAPID-HF: Rate-Adaptive Pacing Doesn’t Help in HFpEF Todd Neale March 05, 2023
News Daily News Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression L.A. McKeown February 17, 2023
News Daily News Angioedema Risk No Higher With ARNI Than With ACE Inhibitors, ARBs Todd Neale January 23, 2023
Video » Interview Beyond the Data: Semaglutide in Heart Failure—a Big STEP-HFpEF Forward? August 27, 2023